Adnkronos (Adnkronos) – "Our collaboration with NTC has been extremely fruitful, developing over the last ten years within our Group, which comprises three production sites. Together with NTC, we have developed several products, both medical devices and pharmaceuticals, which we now produce at all three of our plants with impressive continuity. Their ability to penetrate markets and provide us with timely information, especially for planning, is a great help."
Flavio Lamoure, CEO of Content Group, said this yesterday in Milan at the event celebrating the tenth anniversary of NTC (Novelty, Technology, Care), a leading player in European ophthalmology and the first Italian company to launch ophthalmic products on a global scale.
“Having a clear vision of future needs and potential supply issues, we were able to support them in their growth in their markets and, at the same time, we had the opportunity to enter markets where we were not yet present.
This was also possible thanks to important collaborations in the development of medical devices and pharmaceuticals,” he adds. “It has been an ongoing and very intense collaboration: NTC is indeed very demanding with our operations, but it is also always very attentive to quality and, above all, to maintaining an ethical relationship with its suppliers.”
“In fact, there is no relationship of subservience, but always of partnership: we discuss and help each other to build a shared vision of the future.
This has allowed us to develop a collaborative model that has contributed to our growth. We've grown tremendously over the years, and this partnership has been one of the most important drivers."
News
webinfo@adnkronos.com (Web Info)